Macrophages in Tumor Microenvironments and the Progression of Tumors
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, TAMs induce immunosuppression via release of IL-10 and TGF-β, both of which inhibit the development of cytotoxic T cells and NK cells, and may fuel the appearance of more M2-like TAMs at the tumor site (8, 67, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cancer, tumor-associated macrophages (TAMs) have been known to either promote or hinder neoplasia (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
In the citing paper
“In contrast, M2 macrophages (CD163) play an anti-inflammatory and pro-tumor role”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
In the citing paper
“TAMs often exhibit an “M2-like” phenotype [324].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 2×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“, tumor necrosis factor-α (TNF-α)) [6] (Figure 1).”
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“Finally, M2c macrophages are induced by IL-10, transforming growth factor-β (TGF-β), or glucocorticoids (GCs) [7] (Figure 1).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 7×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
Background
Research works printed but not linked: 12
- 2008, Journal of Immunology, 15, 3733
- 2002, American Journal of Pathology, 161, 947, 10.1016/s0002-9440(10)64255-1 · DOI · Paper page
- 2005, Oncology Reports, 14, 425
- 1996, Journal of Immunology, 156, 73
- 1997, Journal of Immunology, 159, 770
- 1995, Journal of Immunology, 154, 1280
- 2000, Cancer Research, 60, 2632
- 1999, International Journal of Cancer, 84, 539
- 1984, Annual Review of Immunology, 2, 283, 10.1146/annurev.iy.02.040184.001435 · doi:10.1146/annurev.iy.02.040184.001435 · Paper page
- 2003, Cancer Research, 63, 8360
- 1995, Cancer Research, 55, 1499
- 2003, Cancer Research, 63, 7853
Cited by
Items 901–1,000 of 1,000
Castillo, M. Z. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-31072017-125708
Targeting and inhibition of tumor-associated macrophages in breast cancer
Binnemars‐Postma, K. (2017) · doi:10.3990/1.9789036544627
Papel da enzima oxido nítrico sintase induzível na infecção por Neospora caninum
Barros, P. D. S. C. (2014) · doi:10.14393/ufu.di.2014.328 · Cited by 1
Aldujaily, E. (2017) · Figshare
Atiya, H. I. (2018) · Scholar Commons (University of South Carolina)
The effect of cigarette smoke extract on macrophages
Sharaf, A. (2018) · Nottingham ePrints (University of Nottingham)
Pantke, M. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7648
Investigating the support mechanisms provided by macrophages in human erythropoiesis
Diez-Sevilla, I. (2017) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-qr1j1gb02
Role of stromal SPARC in PDAC tumorigenesis and drug delivery
Ramu, I. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7723
Papargyris, L. (2019) · theses.fr (ABES) · doi:10.70675/bd1f051czaa9ez43d1z996dz1ea888022071 · Cited by 1
Raffalla, N., Helal, S., El-Latif, A. A. E.-B. A., & Elsaka, R. O. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i1.35940
“Our study also included the assessment of macrophage density, at least two populations of macrophages with opposite immunological roles have been identified; as double edge swords, the M1 (classically activated) type with a proinflammatory antitumoral function and the M2 (alternatively activated) type with an immunosu…”
BackgroundLi, T., Hui, W., Halike, H., & Gao, F. (2020) · doi:10.21203/rs.3.rs-101882/v1
“Previous studies reported that M2-tumor-associated macrophages (M2-TAMs) were common in malignant tumors, which creates a favorable microenvironment for tumor progression [40, 41].”
BackgroundPrognostic Biomarker MUC4 Mutations in Colon Adenocarcinoma Correlating with Tumor MicroenvironmentPreprint
Li, T., Hui, W., & Gao, F. (2021) · Research Square · doi:10.21203/rs.3.rs-137615/v1
Müller, M.-F. (2013) · publish.UP (University of Potsdam)
Assénat, E., Akkari, L., Moreau, M., & Hibner, U. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.002
Anesthesia and Cancer Recurrence
Goneppanavar, U., & Kaur, J. (2021) · Springer eBooks · doi:10.1007/978-981-16-0006-7_3
Simpson, K. E., Heumen, G. C.-V., Watson, K. L. M., Roth, M., Martin, C., & Moorehead, R. A. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01784-4 · Cited by 18
de Souza, A. M. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2020.tde-20072021-164522
Shrihari, T. (2018) · Journal of Analytical Oncology · doi:10.30683/1927-7229.2018.07.04.4
Shrihari, T. (2018) · Journal of Analytical Oncology · doi:10.30683/1927-7229.2018.07.04.3
(2021) · PeerJ · doi:10.7287/peerj.12383v0.2/reviews/2
“TAMs were found to participate in the occurrence and development of breast cancer by promoting breast cancer cell proliferation (Ning-Bo et al. 2012), promoting breast cancer angiogenesis (Christian et al. 2010; Tsutsui et al. 2005), mediating immunosuppression (Vasievich & Huang 2011), and…”
(2020) · Cancer Studies and Therapeutics · doi:10.31038/cst.2020513
Giese, M. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1419-3_2
The Role of Langerin⁺ CD8α⁺ Dendritic Cells in Tumour Immunotherapy
Gibbins, J. D. (2014) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17008219.v1
Immunogenetic mechanisms in the treatment of cancer
Shah, R., Bhat, A., Qadri, R. A., & Kumar, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90250-2.00014-5
Metabolic requirement for macrophages
Hastreiter, A. A., Paredes, L. C., & Câmara, N. O. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821385-8.00010-x
Tumor-associated macrophages in prostate cancer: role in progression and therapy
Mehta, A., Rawat, S. G., Ratre, Y. K., Soni, V. K., Shukla, D., Kumar, A., & Vishvakarma, N. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85496-2.00028-2
Yusof, N. M., Fuadi, N. N. A. M. N., Hamid, M., Alitheen, N. B., Hanafi, N. M., & Rahman, N. M. A. N. A. (2022) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.18.6.18
Innovative Approaches in Urological Cancers
ScopeMedical, A. (2014) · EMJ Urology · doi:10.33590/emjurol/10310103
Weiss, S. A., Djureinovic, D., Jessel, S., Krykbaeva, I., Zhang, L., Jilaveanu, L. B., Ralabate, A. L., Johnson, B. A., Levit, N. S., Anderson, G., et al. (2023) · doi:10.1158/1078-0432.22480424
Weiss, S. A., Djureinovic, D., Jessel, S., Krykbaeva, I., Zhang, L., Jilaveanu, L. B., Ralabate, A. L., Johnson, B. A., Levit, N. S., Anderson, G., et al. (2023) · doi:10.1158/1078-0432.c.6530444
Tähtinen, S., Grönberg-Vähä-Koskela, S. A. M., Lumén, D., Merisalo-Soikkeli, M., Siurala, M., Airaksinen, A. J., Vähä-Koskela, M. J. V., & Hemminki, A. (2023) · doi:10.1158/2326-6066.c.6548728.v1
Data from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Wu, L., Wu, W., Zhang, J., Zhao, Z., Li, L., Zhu, M., Wu, M., Wu, F., Zhou, F., Du, Y., et al. (2023) · doi:10.1158/2159-8290.c.6549780.v1
Data from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Wu, L., Wu, W., Zhang, J., Zhao, Z., Li, L., Zhu, M., Wu, M., Wu, F., Zhou, F., Du, Y., et al. (2023) · doi:10.1158/2159-8290.c.6549780
Multicellular network analysis of melanoma heterogeneity by scRNA-seq.
Li, S., & Chen, L. (2023) · PubMed Central
Quantificação dos macrófagos M1 e M2 associados a mastocitomas cutâneos caninos
Leite, N. G. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.74.2023.tde-07072023-090418
Macrophage depletion enhances gut dysbiosis and severity in sepsis mouse model
Hiengrach, P. (2022) · Chula Digiverse · doi:10.58837/chula.the.2022.234
Montezzo, D. E. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-17112023-124059 · Cited by 1
Mesenchymal stem cells—role in tuberculosis pathogenesis and persistence
Bajeli, S., Singh, S., Rajpurohit, R. S., Thakran, R., Datta, S., & Kumar, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95545-4.00022-0
Bhattacharya, M., & Samanta, D. (2024) · IP Indian Journal of Immunology and Respiratory Medicine · doi:10.18231/j.ijirm.2023.026
Zhu, M., Li, X., Xu, C. W., Yi, X., Ye, F., Li, X., Hu, Z., Zhang, L., Nie, J. J., & Li, X. (2022) · Figshare · doi:10.6084/m9.figshare.19738555
Zhu, M., Li, X., Xu, C. W., Yi, X., Ye, F., Li, X., Hu, Z., Zhang, L., Nie, J. J., & Li, X. (2022) · Figshare · doi:10.6084/m9.figshare.19738552
Weiss, A., D’Amata, C., Pearson, B. J., & Hayes, M. N. (2024) · eLife · doi:10.7554/elife.93077.2 · Cited by 2
Chemotherapy or Immunotherapy: A Search for the Potential Anti-Cancer Treatment Strategies
Bhattacharya, A., & Guha, D. (2021) · International Journal of Science and Research (IJSR) · doi:10.21275/sr21123211834 · Cited by 1
Cellular Drug Delivery Vehicle
Li, J., Liu, Y., & Hu, X. (2025) · Springer eBooks · doi:10.1007/978-981-19-8930-8_8
A narrative review on tumor microenvironment in malignant tumors
Doğanyiğit, Z., Eroğlu, E., Okan, A., & Yılmaz, S. (2025) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2025-0005
A comprehensive study of Mapping of Hypoxia and acidosis using Advanced MRI technique.
Malhotra, B., Barna, A., & Rai, S. (2025) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2025.v07i03.45423
ONKOLOGIK KАSАLLIKLАRDА MАKROFАGLАR MORFOLOGIYASI VА FUNKSIYALАRI
Asqarov, I. R., Mamatova, I., & Erkinjonovna, F. G. (2025) · Journal of Chemistry of Goods and Traditional Medicine · doi:10.55475/jcgtm/vol3.iss6.2024.474
Mechanisms Underlying Tumor-Associated Macrophages (TAMs)-Facilitated Metastasis
Aleebrahim‐Dehkordi, E., Deravi, N., Fallahi, M. S., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_66 · Cited by 1
The Role of Macrophages in Pancreatic Cancer and Their Potential as Therapeutic Targets
龚, 锐. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15102892
Anand, V., Oderinde, B., Siddiqui, M., Tyagi, A., Borgman, J., Wu, C., Andreeff, M., & Battula, V. L. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00843-7
“…in solid tumors has been more modest than that in hematologic malignancies, largely due to the immunosuppressive microenvironment that these tumors foster 53,56 , which impairs the cytotoxic functions of immune effector cells, such as NK cells, cytotoxic T cells, and macrophages 54,55,58 – 60 .”
Developing antisense therapeutics for multiple myeloma
Kapphahn, A., Truong, N., Khan, M., Ashitey, A., Alfano, D., & Gupta, A. (2025) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2025.102923
Perri, G., Candido, R., Soares, L. B., Ortiz, R. C., de CAMARGO, I., Nogueira, M. R. S., Mello, E. J. F., Coelho, A. L., Posadas, E. M., Hogaboam, C. M., et al. (2025) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2025-0380
Jardim, M. G. D. (2014) · Americanae (AECID Library)
Devil Facial Tumour Disease: In vivo studies in mice
Pinfold, T. L. (2014) · UTAS Research Repository · doi:10.25959/23242457
Indino, S. (2023) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/indino-serena-lucia_phd2023-01-27
Cong, L., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Figshare · doi:10.6084/m9.figshare.14562708
Zhu, M., Li, X., Cheng, X., Yi, X., Ye, F., Li, X., Hu, Z., Zhang, L., Nie, J. J., & Li, X. (2022) · Figshare · doi:10.6084/m9.figshare.19738558
Guo, X., Zhang, H., He, C., Qin, K., Lai, Q., Fang, Y., Chen, Q., Li, W., Wang, Y., Wang, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25310142
Guo, X., Zhang, H., He, C., Qin, K., Lai, Q., Fang, Y., Chen, Q., Li, W., Wang, Y., Wang, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26686815
Cong, L., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Figshare · doi:10.6084/m9.figshare.14562711
Kanwore, K., Kanwore, K., Guo, X., Xia, Y., Zhou, H., Zhang, L., Adzika, G. K., Joseph, A.-A., Abiola, A. A., Peipei, M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24309956
Kanwore, K., Kanwore, K., Guo, X., Xia, Y., Zhou, H., Zhang, L., Adzika, G. K., Joseph, A.-A., Abiola, A. A., Peipei, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24310008
Guo, X., Zhang, H., He, C., Qin, K., Lai, Q., Fang, Y., Chen, Q., Li, W., Wang, Y., Wang, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25310257
Guo, X., Zhang, H., He, C., Qin, K., Lai, Q., Fang, Y., Chen, Q., Li, W., Wang, Y., Wang, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26686818
Guo, X., Zhang, H., He, C., Qin, K., Lai, Q., Fang, Y., Chen, Q., Li, W., Wang, Y., Wang, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26686812
Lu, L., Wang, L., Peng, C., Chen, L., He, X., Shao, C., Wang, C., & Ge, R. (2024) · Figshare · doi:10.6084/m9.figshare.26709590
Lee, S. W., Kim, S., Kim, B., Seong, J. B., Park, Y.-H., Lee, H. J., Choi, D. K., Yeom, E., & Lee, D.-S. (2024) · Figshare · doi:10.6084/m9.figshare.26982099
Lee, S. W., Kim, S., Kim, B., Seong, J. B., Park, Y.-H., Lee, H. J., Choi, D. K., Yeom, E., & Lee, D.-S. (2024) · Figshare · doi:10.6084/m9.figshare.26982096
Wang, J., Ling, D., Shi, L., Li, H., Peng, M., Wen, H., Liu, T., Liang, R., Lin, Y., Wei, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26636574
Anticancer targeted agent combination
Braña, I., & de Medicina, U. A. D. B. D. (2017) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
THE ROLE OF SPARC IN THE IMMUNE LANDSCAPE OF BLADDER CANCER
Hegarty, A. A. (2023) · WakeSpace Scholarship (Wake Forest University)
Bordoni, D. (2023) · MACAU: Open Access Repository of Kiel University
(2019) · Arizona State University Library Digital Repository (Arizona State University)
Metadata
- Authors
- Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M.
- Affiliations
- Army Medical University (CN)
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
- Biomedical Analysis Center, Third Military Medical University, Chongqing 40038, China
- Corresponding author
- Zhang, Zhi-Ren
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3385963
- OpenAlex
- W2106027870
- Cited by
- 1,003
- References
- 121
- Citations by year
- 2026: 28 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 81 · 2021: 109 · 2020: 86 · 2019: 60 · 2018: 65 · 2017: 70 · 2016: 73 · 2015: 85 · 2014: 69 · 2013: 68 · 2012: 2
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor microenvironment, macrophage polarization, M1 macrophages, M2 macrophages, immunosuppression, tumor angiogenesis, metastasis, cancer stem cells, drug resistance, macrophage-targeted therapy
- MeSH terms
- Animals, Humans, Macrophages, Neoplasms, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.